Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing (Q36234355)

12 August 2017

1 reference

title

Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing (English)

1 reference

12 August 2017

0 references

1 reference

Alex J Mitchell

1

0 references

Julián Benito-León

series ordinal

2

object named as

Julián Benito-León

1 reference

12 August 2017

José-Manuel Morales González

series ordinal

3

1 reference

PubMed ID

16109362

12 August 2017

Jesús Rivera-Navarro

series ordinal

4

1 reference

PubMed ID

16109362

12 August 2017

language of work or name

1 reference

1 September 2005

1 reference

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

556-566

1 reference

12 August 2017

9

1 reference

Epidemiology of multiple sclerosis: a critical overview.

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Cognitive impairment in probable multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Encountering the downward phase: biographical work in people with multiple sclerosis living at home.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The neuropsychiatry of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A review about the impact of multiple sclerosis on health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The use of quality of life measures in multiple sclerosis research.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Which chronic conditions are associated with better or poorer quality of life?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The social impact of multiple sclerosis--a study of 305 patients and their relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Health status and quality of life of people with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Relapses and progression of disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A happy state of mind: a history of mild elation, denial of disability, optimism, and laughing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Depression and quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Distinguishing between quality of life and health status in quality of life research: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

What are the determinants of quality of life in people with cervical dystonia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Self-management interventions for chronic illness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Partner relationships, functioning, mood and global quality of life in persons with spinal cord injury and traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Fatigue and depression are associated with poor quality of life in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Domains and determinants of quality of life after stroke caused by brain infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Expectations and quality of life of cancer patients undergoing radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Expectations of wheelchair-dependency in recently diagnosed patients with multiple sclerosis and their partners.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

'It might happen or it might not': how patients with multiple sclerosis explain their perception of prognostic risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Prediction of psychological adjustment to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Self-efficacy predicts self-reported health status in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Measuring self-efficacy in people with multiple sclerosis: a validation study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life among persons with multiple sclerosis and their caregivers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Effects of psychological group therapy in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Social support among persons with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Contributing factors to depressed mood in Multiple Sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Determinants of overall quality of life in secondary progressive MS: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

What drives quality of life in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

1 reference

7 January 2021

Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A critical appraisal of the quality of quality-of-life measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? United Kingdom Collaborators in the International Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The two cultures of medicine: objective facts versus subjectivity and values

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Conceptual and methodological problems in research on the quality of life in clinical medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

One year changes in disability in multiple sclerosis: neurological examination compared with patient self report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The RAND 36-Item Health Survey 1.0.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The SF-36 in multiple sclerosis: why basic assumptions must be tested

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Proxy reliability: health-related quality of life (HRQoL) measures for people with disability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Validation of the functional assessment of multiple sclerosis quality of life instrument

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Developing a disease-specific quality of life measure for people with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life in multiple sclerosis: development and validation of the 'RAYS' scale and comparison with the SF-36

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life index: development and psychometric properties

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Treatment with interferon beta-1b improves quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The impact of outpatient rehabilitation on quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Helping others helps oneself: response shift effects in peer support.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Effects of treatment for depression on fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Doctor-patient communication and cancer patients' quality of life and satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

The psychometric properties of clinical rating scales used in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Comparisons of patient self-report, neurologic examination, and functional impairment in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life: patients and doctors don't always agree: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Quality of life as a predictor for change in disability in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Value of health-related quality of life to predict disability course in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Informal caregiving in multiple sclerosis patients: data from the Madrid Demyelinating Disease Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Neuropsychological aspects of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS ≤ 3.5

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

A questionnaire assessment of unmet needs for rehabilitation services and resources for people with multiple sclerosis: results of a pilot survey in five European countries. Needs Task group of MARCH (Multiple Sclerosis and Rehabilitation, Care and

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

What do people with MS want and expect from health-care services?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970166-6

7 January 2021

10.1016/S1474-4422(05)70166-6

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16109362